HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More…
Industry, Sector and Symbol
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Phone801-727-1000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$287.24 million
Profitability
Miscellaneous
Employees1,141
Next Earnings Date3/16/2020 (Estimated)
OptionableOptionable
Healthequity (NASDAQ:HQY) Frequently Asked Questions
What is Healthequity's stock symbol?
Healthequity trades on the NASDAQ under the ticker symbol "HQY."
How were Healthequity's earnings last quarter?
Healthequity Inc (NASDAQ:HQY) released its earnings results on Tuesday, December, 3rd. The company reported $0.47 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.33. The company earned $157.12 million during the quarter, compared to analyst estimates of $152.38 million. Healthequity had a return on equity of 11.31% and a net margin of 13.03%. Healthequity's revenue for the quarter was up 122.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.25 EPS. View Healthequity's Earnings History.
When is Healthequity's next earnings date?
What guidance has Healthequity issued on next quarter's earnings?
Healthequity updated its FY 2020
After-Hours earnings guidance on Tuesday, December, 3rd. The company provided earnings per share guidance of 1.46-1.52 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.28. The company issued revenue guidance of $520-526 million, compared to the consensus revenue estimate of $517.31 million.
What price target have analysts set for HQY?
13 Wall Street analysts have issued 12 month target prices for Healthequity's stock. Their forecasts range from $56.00 to $95.00. On average, they expect Healthequity's stock price to reach $77.50 in the next twelve months. This suggests a possible upside of 7.9% from the stock's current price. View Analyst Price Targets for Healthequity.
What is the consensus analysts' recommendation for Healthequity?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 1 hold rating, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Healthequity.
Has Healthequity been receiving favorable news coverage?
Press coverage about HQY stock has trended positive recently, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Healthequity earned a daily sentiment score of 2.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Healthequity.
Are investors shorting Healthequity?
Healthequity saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 5,690,000 shares, an increase of 14.5% from the November 28th total of 4,970,000 shares. Based on an average daily trading volume, of 698,900 shares, the days-to-cover ratio is currently 8.1 days. Currently, 8.2% of the company's shares are sold short. View Healthequity's Current Options Chain.
Who are some of Healthequity's key competitors?
Some companies that are related to Healthequity include Akamai Technologies (AKAM), Broadridge Financial Solutions (BR), LYFT (LYFT), Fair Isaac (FICO), The Western Union (WU), Zillow Group (ZG), Zillow Group (Z), WEX (WEX), Nielsen (NLSN), CDK Global (CDK), Etsy (ETSY), Alliance Data Systems (ADS), GrubHub (GRUB), MAXIMUS (MMS) and Ritchie Bros. Auctioneers (RBA).
What other stocks do shareholders of Healthequity own?
Who are Healthequity's key executives?
Healthequity's management team includes the folowing people:
- Mr. Jon Kessler, Pres, CEO & Director (Age 51)
- Stephen D. Neeleman, Founder & Vice Chairman (Age 51)
- Mr. Darcy G. Mott, Exec. VP & CFO (Age 66)
- Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 46)
- Mr. William Robert Otten, Exec. VP of Sales (Age 54)
Who are Healthequity's major shareholders?
Healthequity's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Peregrine Capital Management LLC (0.35%), Summit Creek Advisors LLC (0.23%), Scout Investments Inc. (0.17%), Steward Partners Investment Advisory LLC (0.04%), Gradient Investments LLC (0.03%) and Keeler Thomas Management LLC (0.03%). Company insiders that own Healthequity stock include Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan and Stephen Neeleman. View Institutional Ownership Trends for Healthequity.
Which major investors are selling Healthequity stock?
HQY stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Scout Investments Inc., AE Wealth Management LLC, State of Alaska Department of Revenue, Diversified Trust Co and Keeler Thomas Management LLC. Company insiders that have sold Healthequity company stock in the last year include Angelique Christine Hill, Darcy G Mott, Delano Ladd and Frank Corvino. View Insider Buying and Selling for Healthequity.
Which major investors are buying Healthequity stock?
HQY stock was acquired by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Steward Partners Investment Advisory LLC, Sciencast Management LP, Janney Montgomery Scott LLC, Gradient Investments LLC, Zurcher Kantonalbank Zurich Cantonalbank , Lenox Wealth Advisors LLC and Nisa Investment Advisors LLC. View Insider Buying and Selling for Healthequity.
How do I buy shares of Healthequity?
Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Healthequity's stock price today?
One share of HQY stock can currently be purchased for approximately $71.84.
How big of a company is Healthequity?
Healthequity has a market capitalization of $5.09 billion and generates $287.24 million in revenue each year. The company earns $73.90 million in net income (profit) each year or $0.95 on an earnings per share basis. Healthequity employs 1,141 workers across the globe.View Additional Information About Healthequity.
What is Healthequity's official website?
How can I contact Healthequity?
Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]
MarketBeat Community Rating for Healthequity (NASDAQ HQY)
MarketBeat's community ratings are surveys of what our community members think about Healthequity and other stocks. Vote "Outperform" if you believe HQY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQY will underperform the S&P 500 over the long term. You may vote once every thirty days.
